Assessment of survival and cardiotoxicity of adjuvant trastuzumab among HER2 breast cancer patients in an oncology centre in Malaysia / Harissa H Hasbullah … [et al.]
Adjuvant trastuzumab has been used in human epidermal growth factor-2 (HER2) breast cancer to improve survival but with concern of cardiotoxicity. Our study is the first to review efficacy and toxicity of adjuvant trastuzumab in Malaysia. Methods: This is a retrospective cohort study on HER2 non met...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universiti Teknologi MARA Cawangan Selangor
2018
|
Subjects: | |
Online Access: | http://ir.uitm.edu.my/id/eprint/30061/1/AJ_HARISSA%20H.%20ABDULLAH%20JCHC%20B%2018.pdf http://ir.uitm.edu.my/id/eprint/30061/ https://jchs-medicine.uitm.edu.my/images/manuscript/vol3issue1/original-articles/p33-42/Assessment-of-Survival-and-Cardiotoxicity-of-Adjuvant-Trastuzumab-among-HER2-Breast-Cancer-Patients-in-an-Oncology-Centre-in-Malaysia.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
http://ir.uitm.edu.my/id/eprint/30061/1/AJ_HARISSA%20H.%20ABDULLAH%20JCHC%20B%2018.pdfhttp://ir.uitm.edu.my/id/eprint/30061/
https://jchs-medicine.uitm.edu.my/images/manuscript/vol3issue1/original-articles/p33-42/Assessment-of-Survival-and-Cardiotoxicity-of-Adjuvant-Trastuzumab-among-HER2-Breast-Cancer-Patients-in-an-Oncology-Centre-in-Malaysia.pdf